Sexual well-being after menopause: An International Menopause Society White Paper

References

• Fooladi E, Bell RJ, Whittaker AM, Davis SR. Women's expectations and experiences of hormone treatment for sexual dysfunction. Climacteric 2014;17:674–81
   PubMed Web of Science ®Google Scholar
• Tan HM, Marumo K, Yang DY, Hwang TI, Ong ML. Sex among Asian men and women: the Global Better Sex Survey in Asia. Int J Urol 2009;16:507–14
   PubMed Web of Science ®Google Scholar
• Diagnostic and Statistical Manual of Mental Disorders, 5th Edition. Arlington, VA: American Psychiatric Publishing; 2013
   Google Scholar
• McCabe MP, Sharlip ID, Atalla E, et al. Definitions of sexual dysfunctions in women and men: a Consensus Statement from the Fourth International Consultation on Sexual Medicine 2015. J Sex Med 2016;13:135–43
   PubMed Web of Science ®Google Scholar
• Reed GM, Drescher J, Krueger RB, et al. Disorders related to sexuality and gender identity in the ICD-11: revising the ICD-10 classification based on current scientific evidence, best clinical practices, and human rights considerations. World Psychiatry 2016;15:205–21
   PubMed Web of Science ®Google Scholar
• Simon JA, Lukas VA. Distressing sexual function at midlife: unmet needs, practical diagnoses, and available treatments. Obstet Gynecol 2017;130:889–905
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington DC: American Psychiatric Press; 1994
   Google Scholar
• Parish SJ, Goldstein AT, Goldstein SW, et al. Toward a more evidence-based nosology and nomenclature for female sexual dysfunctions. Part II. J Sex Med 2016;13:1888–906
   PubMed Web of Science ®Google Scholar
• Parish SJ, Hahn SR. Hypoactive sexual desire disorder: a review of epidemiology, biopsychology, diagnosis, and treatment. Sex Med Rev 2016;4:103–20
   PubMedGoogle Scholar
• Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 2008;112:970–8
   PubMed Web of Science ®Google Scholar
• Worsley R, Bell RJ, Gartoulla P, Davis SR. Prevalence and predictors of low sexual desire, sexually related personal distress, and hypoactive sexual desire dysfunction in a community-based sample of midlife women. J Sex Med 2017;14:675–86
   PubMed Web of Science ®Google Scholar
• Zeleke BM, Bell RJ, Billah B, Davis SR. Hypoactive sexual desire dysfunction in community-dwelling older women. Menopause 2017;24:391–9
   PubMed Web of Science ®Google Scholar
• Sidi H, Puteh SE, Abdullah N, Midin M. The prevalence of sexual dysfunction and potential risk factors that may impair sexual function in Malaysian women. J Sex Med 2007;4:311–21
   PubMed Web of Science ®Google Scholar
• Tungphaisal S, Chandeying V, Sutthijumroon S, Krisanapan O, Udomratn P. Postmenopausal sexuality in Thai women. Asia Oceania J Obstet Gynaecol 1991;17:143–6
   PubMedGoogle Scholar
• Parish SJ, Nappi RE, Krychman ML, et al. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy. Int J Womens Health 2013;5:437–47
   PubMedGoogle Scholar
• Nappi RE, Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes (VIVA)–results from an international survey. Climacteric 2012;15:36–44
   PubMed Web of Science ®Google Scholar
• Palacios S, Nappi RE, Bruyniks N, Particco M, Panay N. EVES Study Investigators. The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause. Climacteric 2018;21:286–91
   PubMed Web of Science ®Google Scholar
• Chua Y, Limpaphayom KK, Cheng B, et al. Genitourinary syndrome of menopause in five Asian countries: results from the Pan-Asian REVIVE survey. Climacteric 2017;20:367–73
   PubMed Web of Science ®Google Scholar
• Lindau ST, Schumm LP, Laumann EO, Levinson W, O'Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med 2007;357:762–74
   PubMed Web of Science ®Google Scholar
• Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA 2005;294:91–6
   PubMed Web of Science ®Google Scholar
• Wahlin-Jacobsen S, Pedersen AT, Kristensen E, et al. Is there a correlation between androgens and sexual desire in women? J Sex Med 2015;12:358–73
   PubMed Web of Science ®Google Scholar
• Nappi RE, Cucinella L, Martella S, Rossi M, Tiranini L, Martini E. Female sexual dysfunction (FSD): prevalence and impact on quality of life (QoL). Maturitas 2016;94:87–91
   PubMed Web of Science ®Google Scholar
• Dennerstein L, Dudley E, Burger H. Are changes in sexual functioning during midlife due to aging or menopause? Fertil Steril 2001;76:456–60
   PubMed Web of Science ®Google Scholar
• Hayes R, Dennerstein L. The impact of aging on sexual function and sexual dysfunction in women: a review of population-based studies. J Sex Med 2005;2:317–30
   PubMed Web of Science ®Google Scholar
• Hawton K, Gath D, Day A. Sexual function in a community sample of middle-aged women with partners: effects of age, marital, socioeconomic, psychiatric, gynecological, and menopausal factors. Arch Sex Behav 1994;23:375–95
   PubMed Web of Science ®Google Scholar
• Avis NE, Assmann SF, Kravitz HM, Ganz PA, Ory M. Quality of life in diverse groups of midlife women: assessing the influence of menopause, health status and psychosocial and demographic factors. Qual Life Res 2004;13:933–46
   PubMed Web of Science ®Google Scholar
• Blumel JE, Chedraui P, Baron G, et al. Sexual dysfunction in middle-aged women: a multicenter Latin American study using the Female Sexual Function Index. Menopause 2009;16:1139–48
   PubMed Web of Science ®Google Scholar
• Chedraui P, Perez-Lopez FR, San Miguel G, Avila C. Assessment of sexuality among middle-aged women using the Female Sexual Function Index. Climacteric 2009;12:213–21
   PubMed Web of Science ®Google Scholar
• Chedraui P, Perez-Lopez FR, Mezones-Holguin E, San Miguel G, Avila C. Collaborative Group for Research of the Climacteric in Latin America. Assessing predictors of sexual function in mid-aged sexually active women. Maturitas 2011;68:387–90
   PubMed Web of Science ®Google Scholar
• Thomas HN, Thurston RC. A biopsychosocial approach to women's sexual function and dysfunction at midlife: A narrative review. Maturitas 2016;87:49–60
   PubMed Web of Science ®Google Scholar
• Bancroft J, Loftus J, Long JS. Distress about sex: a national survey of women in heterosexual relationships. Arch Sex Behav 2003;32:193–208
   PubMed Web of Science ®Google Scholar
• Fernandez-Alonso AM, Alcaide-Torres J, Fernandez-Alonso IM, Chedraui P, Perez-Lopez FR. Application of the 21-item Vulvovaginal Symptoms Questionnaire in postmenopausal Spanish women. Menopause 2017;24:1295–301
   PubMed Web of Science ®Google Scholar
• Levine KB, Williams RE, Hartmann KE. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause 2008;15:661–6
   PubMed Web of Science ®Google Scholar
• Leon P, Chedraui P, Hidalgo L, Ortiz F. Perceptions and attitudes toward the menopause among middle aged women from Guayaquil, Ecuador. Maturitas 2007;57:233–8
   PubMed Web of Science ®Google Scholar
• Davison SL, Bell RJ, LaChina M, Holden SL, Davis SR. The relationship between self-reported sexual satisfaction and general well-being in women. J Sex Med 2009;6:2690–7
   PubMed Web of Science ®Google Scholar
• Biddle AK, West SL, D'Aloisio AA, Wheeler SB, Borisov NN, Thorp J. Hypoactive sexual desire disorder in postmenopausal women: quality of life and health burden. Value Health 2009;12:763–72
   PubMed Web of Science ®Google Scholar
• Nappi RE, Verde JB, Polatti F, Genazzani AR, Zara C. Self-reported sexual symptoms in women attending menopause clinics. Gynecol Obstet Invest 2002;53:181–7
   PubMed Web of Science ®Google Scholar
• Nappi RE, Albani F, Santamaria V, et al. Hormonal and psycho-relational aspects of sexual function during menopausal transition and at early menopause. Maturitas 2010;67:78–83
   PubMed Web of Science ®Google Scholar
• Gallicchio L, Schilling C, Tomic D, Miller SR, Zacur H, Flaws JA. Correlates of sexual functioning among mid-life women. Climacteric 2007;10:132–42
   PubMed Web of Science ®Google Scholar
• Avis NE, Colvin A, Karlamangla AS, et al. Change in sexual functioning over the menopausal transition: results from the Study of Women's Health Across the Nation. Menopause 2017;24:379–90
   PubMed Web of Science ®Google Scholar
• Davis SR, Castelo-Branco C, Chedraui P, et al. Understanding weight gain at menopause. Climacteric 2012;15:419–29
   PubMed Web of Science ®Google Scholar
• Nackers LM, Appelhans BM, Segawa E, Janssen I, Dugan SA, Kravitz HM. Associations between body mass index and sexual functioning in midlife women: the Study of Women's Health Across the Nation. Menopause 2015;22:1175–81
   PubMed Web of Science ®Google Scholar
• Jackson KL, Janssen I, Appelhans BM, et al. Body image satisfaction and depression in midlife women: the Study of Women's Health Across the Nation (SWAN). Arch Womens Ment Health 2014;17:177–87
   PubMed Web of Science ®Google Scholar
• Nappi RE, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric 2014;17:3–9
   PubMed Web of Science ®Google Scholar
• Portman DJ, Gass ML. Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society. Climacteric 2014;17:557–63
   PubMed Web of Science ®Google Scholar
• Nappi RE, Kingsberg S, Maamari R, Simon J. The CLOSER (CLarifying Vaginal Atrophy's Impact On SEx and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners. J Sex Med 2013;10:2232–41
   PubMed Web of Science ®Google Scholar
• Nappi RE, Palacios S, Panay N, Particco M, Krychman ML. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Climacteric 2016;19:188–97
   PubMed Web of Science ®Google Scholar
• Hunter MM, Nakagawa S, Van Den Eeden SK, Kuppermann M, Huang AJ. Predictors of impact of vaginal symptoms in postmenopausal women. Menopause 2016;23:40–6
   PubMed Web of Science ®Google Scholar
• Masters WH, Johnson VE, Human Sexual Inadequacy. Boston, USA: Little, Brown; 1970
   Google Scholar
• Althof S, Psychogenic impotence: treatment of men and couples. In: Leiblum SR, ed. Principles and Practice of Sex Therapy. New York: Guilford Press; 1989:237–68
   Google Scholar
• Pâquet M, Rosen N, Steben M, Mayrand M, Santerre-Baillargeon M, Bergeron S. Daily anxiety and depressive symptoms in couples coping with vulvodynia: associations with women's pain, women's sexual function and both partners' sexual distress. J Pain 2018;19:552–61
   PubMed Web of Science ®Google Scholar
• Smith K, Pukall C, Boyer S, Psychological and relational aspects of dyspareunia. In: Goldstein A, Pukall, C, Goldstein, I, eds. Female Sexual Pain Disorders: Evaluation and Management. Oxford: Wiley-Blackwell; 2009
   Google Scholar
• Dogan S, Dogan M. The frequency of sexual dysfunctions in male partners of women with vaginismus in a Turkish sample. Int J Impot Res 2008;20:218–21
   PubMed Web of Science ®Google Scholar
• Althof S, Turner L, Levine S, Bodner D, Kursh E, Resnick M. Through the eyes of women: the sexual and psychological responses of women to their partners' treatment with self-Injection or vacuum constriction therapy. J Urol 1992;147:1024–7
   PubMed Web of Science ®Google Scholar
• Fisher W, Rosen R, Eardley I, Sand M, Goldstein I. Sexual experience of female partners of men with erectile dysfunction: The Female Experience of Men’s Attitudes to Life Events and Sexuality (FEMALES) Study. J Sex Med 2005;2:675–84
   PubMed Web of Science ®Google Scholar
• Hobbs K, Symonds T, Abraham L, May K, Morris MF. Sexual dysfunction in partners of men with premature ejaculation. Int J Impot Res 2008;20:512–17
   PubMed Web of Science ®Google Scholar
• Graziottin A. Prevalence and evaluation of sexual health problems–HSDD in Europe. J Sex Med 2007;4:211–19
   PubMed Web of Science ®Google Scholar
• Rosen RC, Maserejian NN, Connor MK, Krychman ML, Brown CS, Goldstein I. Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women. Menopause 2012;19:396–405
   PubMed Web of Science ®Google Scholar
• Hartmann U, Heiser K, Ruffer-Hesse C, Kloth G. Female sexual desire disorders: subtypes, classification, personality factors and new directions for treatment. World J Urol 2002;20:79–88
   PubMed Web of Science ®Google Scholar
• Clayton AH, Goldstein I, Kim NN, et al. The International Society for the Study of Women's Sexual Health process of care for management of hypoactive sexual desire disorder in women. Mayo Clin Proc 2018;93:467–87
   PubMed Web of Science ®Google Scholar
• Cuerva MJ, Gonzalez D, Canals M, et al. The sexual health approach in postmenopause: the five-minutes study. Maturitas 2018;108:31–6
   PubMed Web of Science ®Google Scholar
• Clayton AH, Goldfischer ER, Goldstein I, Derogatis L, Lewis-D'Agostino DJ, Pyke R. Validation of the decreased sexual desire screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD). J Sex Med 2009;6:730–8
   PubMed Web of Science ®Google Scholar
• Johannes CB, Clayton AH, Odom DM, et al. Distressing sexual problems in United States women revisited: prevalence after accounting for depression. J Clin Psychiatry 2009;70:1698–706
   PubMed Web of Science ®Google Scholar
• Atlantis E, Sullivan T. Bidirectional association between depression and sexual dysfunction: a systematic review and meta-analysis. J Sex Med 2012;9:1497–507
   PubMed Web of Science ®Google Scholar
• Lamont J, Bajzak K, Bouchard C, et al. Female sexual health consensus clinical guidelines. J Obstet Gynaecol Can 2012;34:769–75
   PubMedGoogle Scholar
• Randolph JF, Jr, Zheng H, Avis NE, Greendale GA, Harlow SD. Masturbation frequency and sexual function domains are associated with serum reproductive hormone levels across the menopausal transition. J Clin Endocrinol Metab 2015;100:258–66
   PubMed Web of Science ®Google Scholar
• Goldstein I, Kim NN, Clayton AH, et al. Hypoactive sexual desire disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review. Mayo Clin Proc 2017;92:114–28
   PubMed Web of Science ®Google Scholar
• Wierman ME, Arlt W, Basson R, et al. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2014;99:3489–510
   PubMed Web of Science ®Google Scholar
• Kingsberg SA, Althof S, Simon JA, et al. Female sexual dysfunction-medical and psychological treatments, Committee 14. J Sex Med 2017;14:1463–91
   PubMed Web of Science ®Google Scholar
• Kingsberg SA, Rezaee RL. Hypoactive sexual desire in women. Menopause 2013;20:1284–300
   PubMed Web of Science ®Google Scholar
• Goldstein I, Clayton AH, Goldstein AT, Kim NN, Kingsberg S, Textbook of Female Sexual Function and Dysfunction: Diagnosis and Treatment. Hoboken, NJ: Wiley-Blackwell; 2018
   Google Scholar
• Brotto L, Atallah S, Johnson-Agbakwu C, et al. Psychological and interpersonal dimensions of sexual function and dysfunction. J Sex Med 2016;13:538–71
   PubMed Web of Science ®Google Scholar
• Brotto LA, Goldmeier D. Mindfulness interventions for treating sexual dysfunctions: the gentle science of finding focus in a multitask world. J Sex Med 2015;12:1687–9
   PubMed Web of Science ®Google Scholar
• Brotto LA, Basson R, Luria MA. mindfulness-based group psychoeducational intervention targeting sexual arousal disorder in women. J Sex Med 2008;5:1646–59
   PubMed Web of Science ®Google Scholar
• Annon JS. The PLISSIT Model: a proposed conceptual scheme for the behavioral treatment of sexual problems. J Sex Educ Ther 2015;2:1–15
   Google Scholar
• Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2015;100:3975–4011
   PubMed Web of Science ®Google Scholar
• Santen RJ, Stuenkel CA, Davis SR, Pinkerton JV, Gompel A, Lumsden MA. Managing menopausal symptoms and associated clinical issues in breast cancer survivors. J Clin Endocrinol Metab 2017;102:3647–61
   PubMed Web of Science ®Google Scholar
• Bouchard C, Labrie F, Archer DF, et al. Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophy. Climacteric 2015;18:590–607
   PubMed Web of Science ®Google Scholar
• Bell RJ, Rizvi F, Islam MR, Davis SR. A systematic review of intravaginal testosterone for the treatment of vulvovaginal atrophy. Menopause 2018;25:704–9
   PubMed Web of Science ®Google Scholar
• Cruz VL, Steiner ML, Pompei LM, et al. Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women. Menopause 2018;25:21–8
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Levancini M, Cervigni M. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Climacteric 2015;18:757–63
   PubMed Web of Science ®Google Scholar
• Gartoulla P, Worsley R, Bell RJ, Davis SR. Moderate-severe vasomotor and sexual symptoms remain problematic for 60-65 year old women. Menopause 2015;22:694–701
   PubMed Web of Science ®Google Scholar
• Zeleke BM, Bell RJ, Billah B, Davis SR. Vasomotor and sexual symptoms in older Australian women: a cross-sectional study. Fertil Steril 2016;105:149–55.e1 41
   PubMed Web of Science ®Google Scholar
• Kingsberg SA, Krychman M, Graham S, Bernick B, Mirkin S. The Women's EMPOWER Survey: identifying women's perceptions on vulvar and vaginal atrophy and its treatment. J Sex Med 2017;14:413–24
   PubMed Web of Science ®Google Scholar
• Santoro N, Worsley R, Miller KK, Parish SJ, Davis SR. Role of estrogens and estrogen-like compounds in female sexual function and dysfunction. J Sex Med 2016;13:305–16
   PubMed Web of Science ®Google Scholar
• Davis SR, Worsley R, Miller KK, Parish SJ, Santoro N. Androgens and female sexual function and dysfunction–findings from the Fourth International Consultation of Sexual Medicine. J Sex Med 2016;13:168–78
   PubMed Web of Science ®Google Scholar
• Shifren J, Davis SR, Moreau M, et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 study. Menopause 2006;13:770–9
   PubMed Web of Science ®Google Scholar
• Davis SR. Cardiovascular and cancer safety of testosterone in women. Curr Opin Endocrinol Diabetes Obes 2011;18:198–203
   PubMed Web of Science ®Google Scholar
• Alkatib AA, Cosma M, Elamin MB, et al. A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency. J Clin Endocrinol Metab 2009;94:3676–81
   PubMed Web of Science ®Google Scholar
• Elraiyah T, Sonbol MB, Wang Z, et al. Clinical review: The benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis. J Clin Endocrinol Metab 2014;99:3536–42
   PubMed Web of Science ®Google Scholar
• Worsley R, Santoro N, Miller KK, Parish SJ, Davis SR. Hormones and female sexual dysfunction: beyond estrogens and androgens–findings from the Fourth International Consultation on Sexual Medicine. J Sex Med 2016;13:283–90
   PubMed Web of Science ®Google Scholar
• Constantine G, Graham S, Portman DJ, Rosen RC, Kingsberg SA Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial. Climacteric 2015;18:226–32
   PubMed Web of Science ®Google Scholar
• Thorp J, Simon J, Dattani D, et al. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study. J Sex Med 2012;9:793–804
   PubMed Web of Science ®Google Scholar
• Derogatis LR, Komer L, Katz M, et al. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study. J Sex Med 2012;9:1074–85
   PubMed Web of Science ®Google Scholar
• Katz M, DeRogatis LR, Ackerman R, et al. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial. J Sex Med 2013;10:1807–15
   PubMed Web of Science ®Google Scholar
• Simon JA, Kingsberg SA, Shumel B, Hanes V, Garcia M, Jr, Sand M. Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial. Menopause 2014;21:633–40
   PubMed Web of Science ®Google Scholar
• Segraves RT, Clayton A, Croft H, Wolf A, Warnock J. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol 2004;24:339–42
   PubMed Web of Science ®Google Scholar
• Fava M, Rush AJ, Thase ME, et al. 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL. Prim Care Companion J Clin Psychiatry 2005;7:106–13
   PubMedGoogle Scholar
• Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 2004;65:62–7
   PubMed Web of Science ®Google Scholar
• Landen M, Eriksson E, Agren H, Fahlen T. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1999;19:268–71
   PubMed Web of Science ®Google Scholar
• Stahl SM. Targeting circuits of sexual desire as a treatment strategy for hypoactive sexual desire disorder. J Clin Psychiatry 2010;71:821–2
   PubMed Web of Science ®Google Scholar
• Clayton AH, Althof SE, Kingsberg S, et al. Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial. Womens Health (Lond) 2016;12:325–37
   PubMed Web of Science ®Google Scholar
• Tuiten A, van Rooij K, Bloemers J, et al. Efficacy and safety of on-demand use of 2 treatments designed for different etiologies of female sexual interest/arousal disorder: 3 randomized clinical trials. J Sex Med 2018;15:201–16
   PubMed Web of Science ®Google Scholar
• Pyke R, Katz M, Segraves RT, Sitchon N, Phase IIa study of a proprietary combination of bupropion and trazodone for hypoactive sexual desire disorder (HSDD) in premenopausal women: novel responder and remitter results [poster]. Presented at Annual Meeting of American Society of Clinical Psychopharmacology; Miami FL, USA; 22–25 June, 2015
   Google Scholar